CUSIP N62509117*W EXP 99/99/999Q4 2025
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 500.3K | $11.51M |
| 2 | Ra Capital Management, L.P. | 333.3K | $7.67M |
| 3 | Affinity Asset Advisors, LLC | 245.0K | $5.63M |
| 4 | Bain Capital Life Sciences Investors, LLC | 100.0K | $2.30M |
| 5 | Deerfield Management Company, L.P. | 92.8K | $2.13M |
| 6 | Aristeia Capital, L.L.C. | 15.7K | $397.0K |
| 7 | Cibc Private Wealth Group LLC | 1.0K | $25.3K |
| 8 | Ubs Group AG | 396 | $9.3K |
| 9 |
| Vestcor Inc |
| 9.6K |
| $239 |